Investment Diligence and Financial Safeguards Principal

The mandate

A controlled technology services portfolio is considering a minority investment in a specialist delivery business whose reported earnings and cash needs have not been independently reconciled. The project will deliver an Investment Diligence and Financial Safeguards File for that single proposed investment. It supports a committee decision and appropriate financial conditions, not a recommendation to invest regardless of findings or a promise that the transaction will complete.

The assignment starts on 26 October 2026 for six months, with three days each week reserved. Its artifacts are an earnings and obligation diagnostic, a financial downside and safeguards paper, and a reproducible committee evidence pack. The consultant will distinguish source-supported findings from management representations and identify which legal, tax or technical conclusions require separate qualified work before the investment can be responsibly considered.

Milestone one on 30 November 2026 provides the source reconciliation and diligence issues register. Milestone two on 8 February 2027 delivers the downside cash cases and proposed financial information, approval and funding conditions. The final milestone on 26 April 2027 supplies the completed committee file, internal reviewer replay and responsibility transfer, spanning the whole six-month term even if the investment timetable changes.

The Investment Committee Sponsor and Platform Finance Chief accept each stage against documented evidence tests. Material earnings adjustments must lead back to transaction records; cash obligations must be distinguished from accounting accruals; proposed safeguards must explain the financial exposure they address. An internal reviewer must reproduce two agreed adjustments and the adverse cash case. Acceptance is independent of investment approval, negotiation success or eventual target performance.

The sponsor provides authorised target records, investment assumptions, access to commercial evidence owners and three protected analysts. Payment is 30% on diagnostic acceptance, 40% on safeguards-paper acceptance and 30% on the final transferred file. Legal drafting of shareholder rights, tax advice and a technology security opinion are excluded. Additional targets or expanded transaction periods require a written scope change with revised evidence and commercial terms.

What you will own

• Reconcile material revenue, cost and earnings claims to authorised target records, producing an adjustment trail that distinguishes recurring performance from timing, related-party or unsupported management representations in the first artifact.
• Inventory cash obligations and funding dependencies, identifying where reported profit fails to explain the resources required to maintain delivery or meet commitments after the proposed investment enters the business.
• Develop adverse cases for customer concentration, collection delay and delivery cost, showing the committee how each affects cash needs without presenting scenario assumptions as a forecast guarantee.
• Design proposed financial information and approval safeguards linked to identified exposures, coordinating with legal specialists who determine how any shareholder rights could be validly documented and implemented.
• Prepare the second-stage safeguards paper with alternatives, distinguishing risks addressed through conditions from uncertainties directors would knowingly retain if they elected to support the investment.
• Assemble the final committee evidence pack with source lineage and scope limitations, ensuring a reader can inspect the basis for the financial conclusions without reconstructing the original consultant interviews.
• Conduct an internal reviewer replay of earnings adjustments and the adverse cash case, correcting unclear reasoning and transferring the agreed financial monitoring responsibilities before final sponsor acceptance.

Candidate qualifications

• At least seven years of finance experience should include personally led investment diligence, multi-unit finance or financial controls work in technology services or a related operating sector. Describe a target whose reported earnings changed after source reconciliation, identify the adjustment you established and explain the committee decision or condition that your finding supported.
• A recognised accounting qualification and strong transaction-level judgement are required. Candidates must distinguish profit adjustments, cash commitments and management assertions, preserving the evidence supporting each conclusion. Explain how you handled incomplete records without either abandoning the whole assessment or converting an unsupported explanation into a favourable diligence finding simply to maintain transaction momentum.
• Applicants should demonstrate financial safeguard design or investment governance experience proportionate to a minority stake. Show how you connected an identified exposure to information rights, funding conditions or approval requirements, with qualified legal owners retaining drafting and enforceability responsibility. The role requires practical financial interpretation, not claims to independent legal, tax or technical assurance beyond the defined diligence perimeter.
• Consulting delivery evidence must include advance acceptance tests, clear scope boundaries and artifacts transferred to internal reviewers. Reserve three weekly days through the six-month term and explain a replay or challenge that exposed a weakness in your original file. Independence from the target and freedom from an outcome-based investment incentive are important to the credibility of this assignment.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 11 October 2026. Mandate reference CVU-CON-2026-IND-212.